USFDA makes 'certain' observations for Torrent Pharma's Indrad plant

The audit at Indrad plant of the company was carried out by the United
States Food and Drug Administration (USFDA) in April.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-makes-certain-observations-for-torrent-pharmas-indrad-plant/articleshow/69053644.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment